131030.KS · 옵투스제약

South Korea · RS rating 54 · As of 2026-10-14

Price6,070.00 KRW
1-day change+1.0%
RS rating (overall / 1M / 3M / 12M)54 / 79 / 59 / 44
StageDeclining
Composite / Minervini / CANSLIM score27 / 18 / 44
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q+50.0%
Sales growth Q/Q+6.2%
Distance from 52-week high+68.5%
Market cap (USD)$82.3M
Open South Korea in the interactive screener